Ginsenosides (Triterpene Saponins · Adaptogenic · Cognitive Function · Immune Modulation)
| Compound | Ginsenosides (Panaxosides) |
| Chemical class | Terpenoid — Dammarane / Oleanane Triterpene Saponins (family of 100+ compounds) |
| CAS | Various (Rb1: 41753-43-9; Rg1: 22427-39-0; Re: 52286-74-5) |
| Primary source | Panax ginseng (Asian ginseng root), Panax quinquefolius (American ginseng), Panax notoginseng |
| Key applications | Adaptogenic, cognitive function, immune modulation, physical performance |
| Claim strength | Moderate |
| Typical form | Korean Red Ginseng 99% extract; Asian ginseng extract; standardised ginsenoside preparations |
| Buy from Herbuno |
Asian Ginseng Extract Powder → Korean Red Ginseng 99% Extract Powder → |
Name origin: From Panax (Greek: panacea) — reflecting ginseng’s ancient reputation as a cure-all. Ginsenosides (panaxosides) are a large family of steroidal saponins unique to Panax species, named with an R prefix followed by a letter and number (Rb1, Rc, Rd for protopanaxadiol group; Rg1, Re, Rf for protopanaxatriol group; Ro for oleanane-type). Each ginsenoside has distinct pharmacological properties. Traditional use: Asian ginseng (Ren Shen in TCM; Ashwagandha is the Indian analogue — unrelated botanically) has been used for over 2,000 years in East Asian medicine as the supreme qi tonic for vitality, cognitive function, immune support, and longevity. Korean Red Ginseng (steam-processed Panax ginseng root) is the most commercially established ginseng form, with a richer ginsenoside profile due to steaming-induced transformations. Research trajectory: Ginsenosides have an extensive clinical evidence base across cognitive function, physical performance, immune modulation, blood glucose regulation, erectile dysfunction, and anti-fatigue applications. They are among the most intensively studied botanical compounds globally. Commercial source: Korean Red Ginseng 99% Extract Powder and Asian Ginseng Extract from Herbuno. See sourcing options below.
Evidence for Ginsenoside Applications
Cognitive function and memory: Multiple human RCTs and systematic reviews confirm ginseng extract (200–400 mg/day standardised to ginsenosides) improves working memory, attention, and mental fatigue in healthy adults and patients with mild cognitive impairment. Ginsenoside Rg1 is considered the primary cognitive-function active via acetylcholinesterase inhibition, BDNF upregulation, and neuroprotection. Claim strength: Moderate.
Physical performance and anti-fatigue: Multiple RCTs with ginseng extract show improvements in VO2max, exercise time to exhaustion, and perceived exertion. Anti-fatigue mechanisms include mitochondrial biogenesis (PGC-1α activation) and reduction of exercise-induced oxidative stress. Korean Red Ginseng has the strongest athletic performance evidence. Claim strength: Moderate.
Immune modulation: Ginsenosides stimulate NK cell activity, promote macrophage phagocytosis, enhance T-lymphocyte proliferation, and increase interferon-γ production. Human RCTs show improved influenza vaccine immune response and reduced incidence of acute respiratory infections. Claim strength: Moderate.
Blood glucose modulation: Ginsenoside Rb1 improves insulin sensitivity (AMPK and GLUT4 activation in skeletal muscle) and reduces post-prandial glucose. Meta-analysis of human RCTs confirms modest but consistent fasting glucose reductions with ginseng extract supplementation. Claim strength: Moderate.
Asian Ginseng Extract Powder →
Korean Red Ginseng 99% Extract Powder →
Browse Standardised Extract Powders →
Dosage & Formulator Specification
Cognitive and adaptogenic RCT dose: 200–400 mg/day standardised ginseng extract (typically 4–7% ginsenosides by HPLC). Korean Red Ginseng (steamed root) produces a transformed ginsenoside profile including Rg3, Rg5, and Rk1 (not present in white ginseng) — these are considered to have superior bioavailability and potency. Korean Red Ginseng 99% Extract is commercially available at the highest standardisation level, providing a concentrated ginsenoside platform for premium formulations. Asian Ginseng Extract is also available at lower standardisation for broader product lines.
Ginsenoside bioavailability varies significantly by compound: Rb1 and Rc have low direct absorption, requiring gut microbial transformation to Compound K (the primary absorbed metabolite). Rg1 is more directly absorbed. Processing method significantly affects ginsenoside profile — steaming (Korean Red Ginseng) increases Rg3, Rg5, and Rk1 while reducing Rb1, Rc, and Rd. Fermented ginseng preparations increase Compound K content directly.
Frequently Asked Questions — Ginsenosides
What is the difference between Korean Red Ginseng and regular ginseng extract?
Korean Red Ginseng is produced by steaming fresh Panax ginseng root at 98–100°C for several hours, then drying. This process causes partial hydrolysis and isomerisation of major ginsenosides (Rb1, Rc, Rd) into minor ginsenosides (Rg3, Rg5, Rk1, compound K precursors) which are not present in unprocessed white ginseng. Red ginsenosides (particularly Rg3 and Rg5) are considered more bioavailable and potent than their precursors. The 99% specification from Herbuno indicates a highly concentrated extract with the full Korean Red Ginseng ginsenoside profile.
What is Compound K and why is it important?
Compound K (20-O-β-(D-glucopyranosyl)-20(S)-protopanaxadiol) is the primary absorbed form of protopanaxadiol ginsenosides (Rb1, Rc, Rd) after gut microbial deglycosylation. It is the metabolite responsible for most of the anticancer, anti-inflammatory, and neuroprotective effects attributed to these ginsenosides in vivo. Individuals with poor gut microbiota diversity (common in elderly or those on antibiotics) may have significantly reduced Compound K production — explaining variable responses to ginseng in clinical trials. Fermented ginseng preparations that pre-form Compound K are a solution to this bioavailability variability.
Can ginseng interact with warfarin or diabetes medications?
Ginseng extract has mild platelet aggregation inhibitory effects (some ginsenosides) and blood glucose-lowering activity. Standard advisory: include cautionary language for individuals on anticoagulants (warfarin, aspirin, clopidogrel) and antidiabetic medications. Pharmacokinetic interactions with CYP enzyme substrates have been reported in some studies but are generally considered modest at clinical ginseng doses. Standard advisory language is sufficient rather than absolute contraindication for most patients.
Is ginseng safe for continuous long-term use?
Ginseng has a well-established safety profile at 200–400 mg/day for up to 6 months in clinical trials. Some traditional recommendations suggest cycling (8 weeks on, 2 weeks off) to prevent habituation, though this is based on traditional practice rather than controlled clinical evidence. The most commonly reported adverse effects at higher doses are insomnia, headache, and GI discomfort. Contraindicated in oestrogen receptor-positive breast cancer (some ginsenosides have weak estrogenic activity).
Related compounds: Astragalosides, Cycloastragenol, Withanolide A, Bacoside A
Claim-strength scale – High = multiple human RCTs; Moderate = limited trials or strong preclinical convergence; Emerging = early-stage lab or animal data.
← HerbIQ Compound Index · HerbIQ P02: Extraction · HerbIQ P03: Delivery